Bloodstream Infections Due to Multi-drug Resistant Bacteria in the Emergency Department: Prevalence, Risk Factors and Outcomes-a Retrospective Observational Study

Overview

Journal Intern Emerg Med

Publisher Springer

Specialties Emergency Medicine
General Medicine

Date 2024 Jul 13

PMID 39001978

Authors

Nicolo Capsoni

Giulia Maria Azin

Marida Scarnera

Marco Bettina

Riccardo Breviario

Laura Ferrari

Camilla Ferrari

Daniele Privitera

Chiara Vismara

Alessandra Bielli

Filippo Galbiati

Davide Paolo Bernasconi

Marco Merli

Michele Bombelli

Affiliations

Soon will be listed here.

Abstract

Multidrug-resistant organisms (MDROs) are prevalent in patients admitted to the Emergency Department (ED) and increase the risk of inappropriate empirical antibiotic therapy. Risk stratification for MDRO infection is essential to early identify patients requiring empirical broad-spectrum antibiotic therapy, but it remains challenging for emergency physicians. This study aimed to evaluate prevalence, risk factors, and outcomes of patients admitted to the ED with a bloodstream infection (BSI) caused by MDROs. A retrospective observational study enrolling all consecutive adult patients admitted with a BSI to the ED of Niguarda Hospital, Italy, from January 2019 to December 2021 was performed. 757 patients were enrolled, 14.1% with septic shock. 156 (20%) patients had a BSI caused by MDRO: extended-spectrum beta-lactamase (ESBL) producing Enterobacterales were the most prevalent followed by methicillin-resistant Staphylococcus aureus (MRSA). Risk factors for BSI due to MDRO and specifically for ESBL were chronic renal failure (OR 2.2; 95%CI 1.4-3.6), nursing home residency (OR 4.4; 95%CI 1.9-10.2) and antibiotic therapy in the last 90-days (OR 2.6; 95%CI 1.7-4), whereas for MRSA were dialysis (OR 12.3; 95%CI 1.8-83), antibiotic therapy and/or hospital admission in the past 90-days (OR 3.6; 95%CI 1.2-10.6) and ureteral stent or nephrostomy (OR 7.8; 95%CI 1.5-40.9). Patients with BSI due to MDRO had a higher rate of inappropriate empirical antibiotic therapy (50%) and longer length of stay, but no higher in-hospital mortality. Among patients admitted to the ED with a BSI, MDROs are frequent and often associated with inappropriate empirical antibiotic therapy. Specific updated risk factors for MDRO may help clinicians to better identify patients requiring a broader antibiotic therapy in the ED, while awaiting microbiological results.

References

Pfaller M, Carvalhaes C, Smith C, Diekema D, Castanheira M . Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017). Diagn Microbiol Infect Dis. 2020; 97(2):115016. DOI: 10.1016/j.diagmicrobio.2020.115016. View

McDanel J, Schweizer M, Crabb V, Nelson R, Samore M, Khader K . Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review. Infect Control Hosp Epidemiol. 2017; 38(10):1209-1215. DOI: 10.1017/ice.2017.156. View

Picot-Gueraud R, Batailler P, Caspar Y, Hennebique A, Mallaret M . Bacteremia caused by multidrug-resistant bacteria in a French university hospital center: 3 years of collection. Am J Infect Control. 2015; 43(9):960-4. DOI: 10.1016/j.ajic.2015.05.004. View

Micek S, Hampton N, Kollef M . Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection". Antimicrob Agents Chemother. 2018; 62(3). PMC: 5826146. DOI: 10.1128/AAC.00007-18. View

Kollef M . Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000; 31 Suppl 4:S131-8. DOI: 10.1086/314079. View

Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J . Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect. 2011; 17(11):1659-65. DOI: 10.1111/j.1469-0691.2011.03484.x. View

Aliberti S, Di Pasquale M, Zanaboni A, Cosentini R, Brambilla A, Seghezzi S . Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2011; 54(4):470-8. DOI: 10.1093/cid/cir840. View

Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo M . Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med. 2016; 22(3):219-26. DOI: 10.1097/MCP.0000000000000263. View

Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A . Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013; 188(8):985-95. DOI: 10.1164/rccm.201301-0079OC. View

10.

Shorr A, Zilberberg M, Reichley R, Kan J, Hoban A, Hoffman J . Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis. 2011; 54(2):193-8. DOI: 10.1093/cid/cir813. View

11.

Trecarichi E, Cauda R, Tumbarello M . Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol. 2012; 7(10):1173-89. DOI: 10.2217/fmb.12.100. View

12.

Tumbarello M, Trecarichi E, Bassetti M, De Rosa F, Spanu T, Di Meco E . Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother. 2011; 55(7):3485-90. PMC: 3122446. DOI: 10.1128/AAC.00009-11. View

13.

Doern G, Carroll K, Diekema D, Garey K, Rupp M, Weinstein M . Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem. Clin Microbiol Rev. 2019; 33(1). PMC: 6822992. DOI: 10.1128/CMR.00009-19. View

14.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

15.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

16.

Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon A . Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007; 26(5):349-52. DOI: 10.1007/s10096-007-0287-3. View

17.

Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G . Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study. Diagn Microbiol Infect Dis. 2011; 69(4):363-9. DOI: 10.1016/j.diagmicrobio.2010.10.016. View

18.

Aliberti S, Cilloniz C, Chalmers J, Zanaboni A, Cosentini R, Tarsia P . Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013; 68(11):997-9. DOI: 10.1136/thoraxjnl-2013-203384. View

19.

Ewig S, Welte T, Chastre J, Torres A . Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010; 10(4):279-87. DOI: 10.1016/S1473-3099(10)70032-3. View

20.

Baker P, Cohen B, Liu J, Larson E . Incidence and risk factors for community-associated methicillin-resistant Staphylococcus aureus in New York City, 2006-2012. Epidemiol Infect. 2015; 144(5):1014-7. DOI: 10.1017/S095026881500196X. View